Paper39202032
Innovative Implementation Strategies for Familial Hypercholesterolemia Cascade Testing: The Impact of Genetic Counseling.
Morgan KM and 12 others. J Pers Med, 2024. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Innovative Implementation Strategies for Familial Hypercholesterolemia Cascade Testing: The Impact of Genetic Counseling. Papers, record 39202032. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39202032
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Innovative Implementation Strategies for Familial Hypercholesterolemia Cascade Testing: The Impact of Genetic Counseling.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 HL148246 | NHLBI NIH HHS | United States | R01HL148246 | PubMed and NIH |
| R01HL148246 | The National Heart, Lung, And Blood Institute of the National Institutes of Health | R01HL148246 | PubMed and NIH |
Source NIH RePORTER
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30586774 | 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. | Circulation | 2019 | https://conductscience.org/library/papers/30586774 | PubMed |
| 2 | 35960887 | Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis. | J Clin Oncol | 2022 | https://conductscience.org/library/papers/35960887 | PubMed |
| 3 | 23956253 | Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. | Eur Heart J | 2013 | https://conductscience.org/library/papers/23956253 | PubMed |
| 4 | 39238848 | IMPACT-FH Study for Implementing Innovative Family Communication and Cascade Testing Strategies for Familial Hypercholesterolemia. | JACC Adv | 2024 | https://conductscience.org/library/papers/39238848 | PubMed |
| 5 | 24770865 | Evaluating the utilization of educational materials in communicating about Lynch syndrome to at-risk relatives. | Fam Cancer | 2014 | https://conductscience.org/library/papers/24770865 | PubMed |
| 6 | 28168332 | A Rapid Systematic Review of Outcomes Studies in Genetic Counseling. | J Genet Couns | 2017 | https://conductscience.org/library/papers/28168332 | PubMed |
| 7 | 28419271 | Genetic testing for familial hypercholesterolaemia is essential in individuals with high LDL cholesterol: who does it in the world? | Eur Heart J | 2017 | https://conductscience.org/library/papers/28419271 | PubMed |
| 8 | 34200550 | Patient and Family Preferences on Health System-Led Direct Contact for Cascade Screening. | J Pers Med | 2021 | https://conductscience.org/library/papers/34200550 | PubMed |
| 9 | 34327496 | A proof-of-concept study of cascade screening for Familial Hypercholesterolemia in the US, adapted from the Dutch model. | Am J Prev Cardiol | 2021 | https://conductscience.org/library/papers/34327496 | PubMed |
| 10 | 26866580 | The Geisinger MyCode community health initiative: an electronic health record-linked biobank for precision medicine research. | Genet Med | 2016 | https://conductscience.org/library/papers/26866580 | PubMed |
| 11 | 24636175 | Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation. | J Clin Lipidol | 2014 | https://conductscience.org/library/papers/24636175 | PubMed |
| 12 | 32948847 | Barriers and facilitators for cascade testing in genetic conditions: a systematic review. | Eur J Hum Genet | 2020 | https://conductscience.org/library/papers/32948847 | PubMed |
| 13 | 38570510 | Strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review. | NPJ Genom Med | 2024 | https://conductscience.org/library/papers/38570510 | PubMed |
| 14 | 36137613 | Patient-facing digital tools for delivering genetic services: a systematic review. | J Med Genet | 2023 | https://conductscience.org/library/papers/36137613 | PubMed |
| 15 | 25585028 | Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience. | Atherosclerosis | 2015 | https://conductscience.org/library/papers/25585028 | PubMed |
| 16 | 30109451 | Risk Communication in Families of Children with Familial Hypercholesterolemia: Identifying Motivators and Barriers to Cascade Screening to Improve Diagnosis at a Single Medical Center. | J Genet Couns | 2018 | https://conductscience.org/library/papers/30109451 | PubMed |
| 17 | 31638829 | New Case Detection by Cascade Testing in Familial Hypercholesterolemia: A Systematic Review of the Literature. | Circ Genom Precis Med | 2019 | https://conductscience.org/library/papers/31638829 | PubMed |
| 18 | 35322585 | Uptake of genetic counseling and testing in a clinic-based population of women with breast cancer. | Cancer Med | 2022 | https://conductscience.org/library/papers/35322585 | PubMed |
| 19 | 24585182 | Patients' perceptions and experiences of familial hypercholesterolemia, cascade genetic screening and treatment. | Int J Behav Med | 2015 | https://conductscience.org/library/papers/24585182 | PubMed |
| 20 | 33480803 | Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia. | Circ Genom Precis Med | 2021 | https://conductscience.org/library/papers/33480803 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 40844583 | What kind of information is requested by patients and families with genetic disorders? : The analysis of an online patient community in South Korea. | J Community Genet | 2025 | https://conductscience.org/library/papers/40844583 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39202032
GET https://conductscience.org/api/papers/v1/39202032/references?page=2